Ascendis Pharma A/S

XNAS:ASND

224.11

-13.36 (-5.63%)

7:37:49 PM EDT: $224.30 +0.19 (+0.09%)

Market Cap (Intraday)	13.14B
Current PE	22.57
Forward PE	14.39
2yr Forward PE	20.56

See more stats

Estimates Current Quarter

Revenue	$380.73 Million
Adjusted EPS	$1.82

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Ascendis Pharma A/S - ADR Stock, XNAS:ASND

Tuborg Boulevard 12, Hellerup, Capital Region 2900

Denmark

Phone: +45.70.22.22.44

Number of Employees:

http://www.ascendispharma.com

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.